110 related articles for article (PubMed ID: 5457335)
41. NONSPECIFIC ANTI-INFLAMMATORY AGENTS. SOME NOTES ON THEIR PRACTICAL APPLICATION, ESPECIALLY IN RHEUMATIC DISORDERS.
BOLAND EW
Calif Med; 1964 Mar; 100(3):145-55. PubMed ID: 14131394
[TBL] [Abstract][Full Text] [Related]
42. Bio-assay of corticosteroids for topical application.
Spearman RI; Jarrett A
Br J Dermatol; 1975 May; 92(5):581-4. PubMed ID: 1174471
[TBL] [Abstract][Full Text] [Related]
43. [Quantitative determination of prednisone and prednisolone the method of UV-spectrophotometry].
Kovalenko LI; Senov PL
Farm Zh; 1970; 25(4):78-9. PubMed ID: 5487998
[No Abstract] [Full Text] [Related]
44. [Pharmacology of dermatocorticoids (2. Continuation)].
Weirich EG
Z Hautkr; 1978 Apr; 53(7):209-16 contd. PubMed ID: 645170
[No Abstract] [Full Text] [Related]
45. Topical corticosteroids.
Pace WE
Can Med Assoc J; 1973 Jan; 108(1):ll passim. PubMed ID: 4682644
[No Abstract] [Full Text] [Related]
46. [PRINCIPLES OF CORTISONE THERAPY].
KAISER H
Urologe; 1963 Jul; 2():203-10. PubMed ID: 14047047
[No Abstract] [Full Text] [Related]
47. Stability of betamethasone sodium phosphate, hydrocortisone sodium phosphate, and prednisolone sodium phosphate injections submitted by U.S. hospitals.
Kreienbaum MA
Am J Hosp Pharm; 1986 Jul; 43(7):1747-50. PubMed ID: 3752113
[TBL] [Abstract][Full Text] [Related]
48. The characteristic feature of glucocorticoids after local application with reference to leucocyte migration and protein exudation.
Ishikawa H; Mori Y; Tsurufuji S
Eur J Pharmacol; 1969 Aug; 7(2):201-5. PubMed ID: 5345995
[No Abstract] [Full Text] [Related]
49. Intravitreal steroids in the management of macular oedema.
Sivaprasad S; McCluskey P; Lightman S
Acta Ophthalmol Scand; 2006 Dec; 84(6):722-33. PubMed ID: 17083528
[TBL] [Abstract][Full Text] [Related]
50. [Distribution studies with Digitalis-like synthetic steroid-3,20-bisguanylhydrazones-14C].
Duhm B; Maul W; Medenwald H; Patzschke K; Wegner L
Arzneimittelforschung; 1969 Dec; 19(12):1978-81. PubMed ID: 5395890
[No Abstract] [Full Text] [Related]
51. Pressurised liquid extraction and ultra-high performance liquid chromatography-tandem mass spectrometry to determine endogenous and synthetic glucocorticoids in sewage sludge.
Herrero P; Borrull F; Marcé RM; Pocurull E
Talanta; 2013 Jan; 103():186-93. PubMed ID: 23200376
[TBL] [Abstract][Full Text] [Related]
52. Determination of MRL regulated corticosteroids in liver from various species using ultra high performance liquid chromatography-tandem mass spectrometry (UHPLC).
Deceuninck Y; Bichon E; Monteau F; Antignac JP; Le Bizec B
Anal Chim Acta; 2011 Aug; 700(1-2):137-43. PubMed ID: 21742126
[TBL] [Abstract][Full Text] [Related]
53. In vitro and ex vivo binding to uterine progestin receptors of the rat as a tool to assay progestational activity of glucocorticoids.
Luzzani F; Gallico L; Glässer A
Methods Find Exp Clin Pharmacol; 1982; 4(4):237-42. PubMed ID: 7121132
[TBL] [Abstract][Full Text] [Related]
54. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.
Hughes RA; Mehndiratta MM
Cochrane Database Syst Rev; 2012 Aug; (8):CD002062. PubMed ID: 22895925
[TBL] [Abstract][Full Text] [Related]
55. [PROBLEMS IN THE SIDE-EFFECTS OF ADRENAL CORTEX HORMONE THERAPY OF SKIN DISEASES].
NOHARA N; TSUKINOKI K; TODA M
Nisshin Igaku Jpn J Med Prog; 1963 Mar; 50():139-58. PubMed ID: 14058448
[No Abstract] [Full Text] [Related]
56. Comparison of the analysis of corticosteroids using different techniques.
Pujos E; Flament-Waton MM; Paisse O; Grenier-Loustalot MF
Anal Bioanal Chem; 2005 Jan; 381(1):244-54. PubMed ID: 15700162
[TBL] [Abstract][Full Text] [Related]
57. High-pressure liquid chromatographic evaluation of aqueous vehicles for preparation of prednisolone and prednisone liquid dosage forms.
Gupta VD
J Pharm Sci; 1979 Jul; 68(7):908-10. PubMed ID: 37325
[TBL] [Abstract][Full Text] [Related]
58. [FEVER IN CHILDREN. (3)].
SATOMI M
Chiryo; 1963; 45():2223-7. PubMed ID: 14103588
[No Abstract] [Full Text] [Related]
59. Fluocinolone acetonide intravitreal implants in Vogt-Koyanagi-Harada disease.
Khalifa Y; Loh AR; Acharya NR
Ocul Immunol Inflamm; 2009; 17(6):431-3. PubMed ID: 20001265
[TBL] [Abstract][Full Text] [Related]
60. Method development for betamethasone and dexamethasone by micellar liquid chromatography using cetyl trimethyl ammonium bromide and validation in tablets. Application to cocktails.
Peña-García-Brioles D; Gonzalo-Lumbreras R; Izquierdo-Hornillos R; Santos-Montes A
J Pharm Biomed Anal; 2004 Sep; 36(1):65-71. PubMed ID: 15351049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
